Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications

被引：0
|
作者：
Pierre-Michel Llorca
Christophe Lançon
Ann Hartry
T. Michelle Brown
Dana B. DiBenedetti
Siddhesh A. Kamat
Clément François
机构：
[1] CMP B CHU Clermont-Ferrand,
[2] Université Clermont-Auvergne,undefined
[3] Laboratoire de Santé Publique Évaluation des Systèms de Soins et Santé Perçue,undefined
[4] Université de la Méditerranée,undefined
[5] Lundbeck,undefined
[6] RTI Health Solutions,undefined
[7] Research Triangle Park,undefined
[8] Otsuka Pharmaceutical Development Corporation,undefined
来源：
BMC Psychiatry | / 17卷
关键词：
Schizophrenia; Major depressive disorder; Atypical antipsychotics; Treatment-emergent adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications
    Llorca, Pierre-Michel
    Lancon, Christophe
    Hartry, Ann
    Brown, T. Michelle
    DiBenedetti, Dana B.
    Kamat, Siddhesh A.
    Francois, Clement
    [J]. BMC PSYCHIATRY, 2017, 17
  • [2] Treatment-emergent adverse events associated with atypical antipsychotics
    Cha, Danielle S.
    McIntyre, Roger S.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (11) : 1587 - 1598
  • [3] A comparison of treatment-emergent diabetes among atypical and typical antipsychotic users
    Stafkey-Mailey, D. R.
    McCombs, J. S.
    Hay, J. W.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S148 - S149
  • [4] Profile of Sexual and Genitourinary Treatment-Emergent Adverse Events Associated with Atomoxetine Treatment: A Pooled Analysis
    Camporeale, Angelo
    Day, Kathleen Ann
    Ruff, Dustin
    Arsenault, Jody
    Williams, David
    Kelsey, Douglas K.
    [J]. DRUG SAFETY, 2013, 36 (08) : 663 - 671
  • [5] Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder
    Gentile, Salvatore
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (01) : 35 - 45
  • [6] Prucalopride: factors associated with treatment-emergent adverse events in Asian and non-Asians
    Leelakusolvong, Somchai
    Ke, Meiyun
    Duowu, Zou
    Choi, Suck Chei
    Tack, Jan
    Quigley, Eamonn
    Liu, Andy
    Kim, Jinyong
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 352 - 352
  • [7] Profile of Sexual and Genitourinary Treatment-Emergent Adverse Events Associated with Atomoxetine Treatment: A Pooled Analysis
    Angelo Camporeale
    Kathleen Ann Day
    Dustin Ruff
    Jody Arsenault
    David Williams
    Douglas K. Kelsey
    [J]. Drug Safety, 2013, 36 : 663 - 671
  • [8] Association between atypical antipsychotic use and treatment-emergent diabetes, hyperlipidemia, and obesity
    Lingle, E. W.
    Dickson, M.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A292 - A292
  • [9] Risk of treatment-emergent diabetes during clinical trials of olanzapine and other antipsychotic medications
    Toalson, P
    Sowell, M
    Mukhopdhyay, N
    Cavazzoni, P
    Breier, A
    Buse, J
    [J]. PSYCHOSOMATICS, 2003, 44 (02) : 148 - 148
  • [10] Treatment-emergent adverse events and antiseizure medication actual drug load
    Pretat, Tiffany
    Aicua-Rapun, Irene
    Andre, Pascal
    Lebon, Sebastien
    Rossetti, Andrea O.
    Decosterd, Laurent A.
    Buclin, Thierry
    Novy, Jan
    [J]. EPILEPSY & BEHAVIOR, 2022, 137
12345